Last update 24 Jan 2026

ABOR-2013

Overview

Basic Info

Drug Type
Therapeutic vaccine, mRNA vaccine
Synonyms
ABO2013, ABOR2013, ABOR2013T
Target
EGFR x EGFR L858R x EGFR T790M x EGFR-Ex19del
Action
inhibitors, antagonists
Mechanism
EGFR T790M inhibitors(Epidermal Growth Factor Receptor T790M inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), EGFR exon 19 deletion inhibitors
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
EGFR-mutated non-small Cell Lung CancerLung Cancer
Inactive Indication-
Originator Organization
ABON Biopharm (Hangzhou) Co. Ltd.ABON Biopharm (Hangzhou) Co. Ltd.The First Affiliated Hospital of Nanyang Medical College
Active Organization
ABON Biopharm (Hangzhou) Co. Ltd.ABON Biopharm (Hangzhou) Co. Ltd.The First Affiliated Hospital of Guangzhou Medical UniversityThe First Affiliated Hospital of Nanyang Medical College
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ABOR-2013
ChiCTR2300071001
/ RecruitingPhase 1IIT
Dose escalation study evaluating the safety, tolerability, and preliminary efficacy of ABOR2013 monotherapy or in combination with PD-1 monoclonal antibody in advanced non-small cell lung cancer with EGFR positive mutation
100 Clinical Results associated with ABOR-2013
Login to view more data
100 Translational Medicine associated with ABOR-2013
Login to view more data
100 Patents (Medical) associated with ABOR-2013
Login to view more data
100 Deals associated with ABOR-2013
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EGFR-mutated non-small Cell Lung CancerPhase 1
China
The First Affiliated Hospital of Nanyang Medical College
01 Dec 2025
Lung CancerPhase 1
China
ABON Biopharm (Hangzhou) Co. Ltd.ABON Biopharm (Hangzhou) Co. Ltd.
10 May 2023
Lung CancerPhase 1
China
The First Affiliated Hospital of Guangzhou Medical University
10 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free